The US regulator has approved Nexviazyme (avalglucosidase alfa) for the treatment of patients aged one year of age and older with late-onset Pompe disease, which progressively attacks the heart ...

Living with Pompe disease and experiencing muscle weakness it will become known how much the weather and environment can affect your body. I used to get sick every winter because the freezing ...

Maze Therapeutics, Inc.’s MAZE share price has dipped by 5.71%, which has investors questioning if this is right time to buy.

Case study 2: Fabry and Pompe disease treatment reimbursement in the Netherlands Fabry disease is estimated to affect 1 in every 40,000-120,000 people3, while Pompe affects 1 in 14,000-300,0004 ...

Pompe disease is a rare, hereditary disease caused by mutations in a gene called acid ... Their observations, combined with lab work results and the physical therapy evaluation, will help determine if ...

Katy Arvidson of Eagle River will compete this summer in the national pageant, which aims to reduce prejudice and ...

Speakers at the panel “Unlocking the future: the convergence of AI, personalized medicine, and genomics” at the World Orphan Drug Congress USA 2025 (Photo by Riya Ajmera) Artificial intelligence could ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Juan Gomez, director of Neurointerventional Radiology at Jupiter Medical Center, came to tell viewers about a first-of-its-kind treatment option. "Carotid disease, just like any other vascular ...

There is even scientific debate about whether the bacteria and infection persist after antibiotic treatment. “It’s just fundamentally different from basically all other disease-causing agents ...